Filing Details
- Accession Number:
- 0001209191-22-001994
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-05 19:24:13
- Reporting Period:
- 2022-01-03
- Accepted Time:
- 2022-01-05 19:24:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1020214 | Cerus Corp | CERS | Surgical & Medical Instruments & Apparatus (3841) | 680262011 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1574700 | Carol Moore | C/O Cerus Corporation 1220 Concord Ave Suite 600 Concord CA 94520 | Svp Reg. & Quality | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-01-03 | 19,059 | $3.66 | 200,335 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-01-03 | 19,059 | $7.00 | 181,276 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (Right to Buy) | Disposition | 2022-01-03 | 19,059 | $0.00 | 19,059 | $3.66 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
150,941 | 2023-02-28 | No | 4 | M | Direct |
Footnotes
- This transaction was executed pursuant to a 10b5-1 plan.
- This transaction was executed pursuant to a 10b5-1 plan. The sales occurred in multiple trades at prices ranging from $7.000 to $7.005. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter.
- Not applicable.